News Sandoz Group AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:10 2024-05-10 am EDT			5-day change	1st Jan Change
32.55 ^CHF	+3.33%		+5.00%	+20.29%

May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT
May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	May. 08	MT
Swiss Market Index Closes Higher; Sandoz Gains	May. 08	MT
SANDOZ : Sandoz’s improvements are worth betting on	May. 08
SANDOZ : Q1 miss not a worry; expect another boost for the share price	May. 07
Sandoz: 5% sales growth in Q1	May. 07	CF
Transcript : Sandoz Group AG, Q1 2024 Sales/ Trading Statement Call, May 07, 2024	May. 07
Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook	May. 07	MT
Sandoz reports first quarter 2024 sales	May. 07	GL
Sandoz Announces Sales Results for the First Quarter 2024	May. 07	CI
Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	Apr. 30
Sandoz Group AG Announces Appointment of Graeme Pitkethly as Non-Executive Director and Chair of Its Audit, Risk and Compliance Committee	Apr. 30	CI
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG	Apr. 30	GL
Sandoz Group AG Announces Board and Committee Appointments	Apr. 30	CI
Sandoz Group AG Approves Dividend, Payable on May 7, 2024	Apr. 30	CI
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation	Apr. 30	DJ
Sandoz Group Settles Patent Disputes with Amgen	Apr. 30	MT
Sandoz reaches agreement with Amgen over patent dispute	Apr. 30	RE

No results for this search

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 08:08 am EDT